8:00 AM – Welcome & Opening Remarks
REAL TIME Coverage of the Conference by Dr. Aviva Lev-Ari, PhD, RN – Director and Founder of LEADERS in PHARMACEUTICAL BUSINESS INTELLIGENCE, Boston http://pharmaceuticalintelligence.com
Raju Kucherlapati, Ph.D.
Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School
Welcome all attendees, discussing Personalized Medicine, what happened and looking forward — the potential of this approach to Medicine. Event organized with Partner, National Council Cancer Research. Organizing committee and Sponsors made the event possible.
AND
Scott Weiss, M.D., M.S.
Scientific Director, Partners Personalized Medicine;
Associate Director, Channing Laboratory, Professor of Medicine.
Greetings
Victor Dzau, M.D. — ABSENT — By Voice addressing the Audience
President, Institute of Medicine
Advisor on Genomics – In 1996 returned from Stanford to Harvard. What role Genetics and Genomics will play in Medicine.
Boston is a very special place for that endeavor. Harvard allocated $100 Million to study this topic. 10th year of the Conference. I am 100 days at IOM, Genomics and personalized medicine (PM) and Translation Medicine are the center. Spin off in Software development to solicit application in PM. Scientists, payers, technologists — the economics of PM navigate the regulatory. Looking forward for the next 10 years in PM
Edward Abrahams, Ph.D. (@newsfrompmc)
President, Personalized Medicine Coalition
Review the Progress made in PM – it has change, treating the patient not changing the disease. Friendlier between Science and the Medicine.
- 2004 Harvard graduate started Facebook, Viox was recalled,
- Personalized Medicine – drugs increase form 13 in 2003 to 113 in 2013.
- Diagnostics evolution by revolution
- It took 4 years to develop new drug in 2013
- In 20 years 45% of drug approvals – revolution in 155 Pharmacogenomics drugs approved at $12 Billion sales
- FDA encouraged PM – 2017 Diagnostics
- FDA molecular diagnostics test
- Regulatory of tests
- Payers and Manufacturer do not agree on practices
- Education of MDs in PM, 10% had sufficient knowledge in Genomics to incorporate it in Delivery of Care
– See more at: http://personalizedmedicine.partners.org/Education/Personalized-Medicine-Conference/Program.aspx#sthash.qGbGZXXf.dpuf
@HarvardPMConf
#PMConf
@SachsAssociates
Leave a Reply